WO2026110102 - PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/110102
Publication Date
28.05.2026
International Application No.
PCT/IB2025/061964
International Filing Date
21.11.2025
Title **
[English]
PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
[French]
INHIBITEURS DE PROTÉINE TYROSINE PHOSPHATASE ET LEURS MÉTHODES D'UTILISATION
Applicants **
ITEOS BELGIUM SA
Inventors
BONNEL, Clément Marvel Henri
VAN DER PLAS, Steven Emiel
DELIGNY, Michael
Priority Data
63/723,775
22.11.2024
US
63/763,634
26.02.2025
US
63/782,838
03.04.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2453 | |
| EPO | Filing, Examination, Granting | 9840 | |
| Japan | Filing, Examination, Granting | 2207 | |
| South Korea | Filing, Examination, Granting | 2178 | |
| USA | Filing, Examination, Granting | 9540 |
Total:
26,218
Contact Us
Abstract[English]
The present disclose includes, among other things, compounds that inhibit PTPN1 and/or PTPN2, pharmaceutical compositions comprising the compounds, and methods of making and using the same.[French]
La présente divulgation concerne, entre autres, des composés qui inhibent PTPN1 et/ou PTPN2, des compositions pharmaceutiques comprenant lesdits composés, ainsi que des méthodes de fabrication et d'utilisation de ceux-ci.